Abstract: Chalcones (6a-f) have been prepared by the condensation of ketone (5) and different aromatic and heterocyclic aldehydes. These chalcones (6a-f) on treatment with guanidine hydrochloride and phenyl hydrazine hydrochloride in presence of alkali give aminopyrimidines (7a-f) and phenylpyrazolines (8a-f) respectively. All the newly synthesized compounds have been characterized on the basis of IR, 1 H NMR spectral data as well as physical data. Antibacterial activity (minimum inhibitory concentration MIC) against Gram-positive S. aureus MTCC 96 and S. pyogeneus MTCC 442 and Gram-negative P. aeruginosa MTCC 1688 and E. coli MTCC 443 bacteria, as well as antifungal acivity (MIC) against C. albicans MTCC 227, A. niger MTCC 282 and A. clavatus MTCC 1323 were determined by broth dilution method.
Introduction
Commonly α, β -unsaturated ketone is known as chalcone. Chalcones 1,2 are very reactive compounds and increase their reactivity due to keto-ethylinic type of conjugated double bond system present in the molecule. Chalcones have occupied unique place in medicinal and biological chemistry due to their diverse pharmacological properties such as anticancer 3 , anti-inflammatory 4 , antiviral 5 and antibacterial 6 etc…. Five membered heterocyclic like pyrazolines have found wide application as pharmaceutical and agrochemical agents. Pyrazoline derivatives have been found to possess wide range of therapeutic activities such as diuretic 7 , antifungal 8 , analgesic 9 , and mollucicidal 10 etc…. Pyrimidine derivatives play a vital role in many biological processes and in synthesis of many drugs. Many pyrimidine derivatives have displayed diverse biological activities such as antitumor 11 , hypnotensive 12 , antiulcer 13 , and anticonvulsant 14 etc… In view of the above and in a continuation of our work [15] [16] [17] on chalcones and its derivatives, we herein report a new series of chalcones (6a-f), aminopyrimidines (7a-f), and phenylpyrazolines (8a-f).
Experimental
All melting points were determined in open capillary and are uncorrected. The IR spectra were recorded on a FTIR -8400 spectrometer. 1 H NMR spectra on a Bruker Avance DPX 400 MHz spectrometer with CDCl 3 as a solvent and tetramethylsilane (TMS) as internal standard. The chemical shifts are expressed in parts per million (ppm) downfield from the internal standard and signals are quoted as s (singlet) and m (multiplate). Analytical separation was conducted with silica Gel 60 F-254 (Merck) plates of 0.25 mm thickness eluted with toluene : acetone (10 : 2 v/v) and were visualized with UV (254 nm) or iodine to check the purity of the synthesized compounds.
Preparation of 2-(2', 4'-difluorophenylamino)-4, 6-dichloro-s-triazine (3)
2, 4-Difluoroaniline (0.01 mol, 1.29g in 10mL acetone) was added slowly to cyanuric chloride (0.01 mol, 1.845g in 30mL acetone) with constant stirring for 4 hours at 0 to 5 0 C. Periodically, sodium carbonate solution (0.005 mol, 0.53g in 10 mL water) was added drop wise to neutralized HCl evolved during the reaction. The progress of the reaction was monitored on TLC plate. Finally, the content was poured into crushed ice. The solid seprated out was filtered, washed with water, dried and recrystallised from alcohol to give (3).
Preparation of 2, 4-bis-(2', 4'-difluorophenylamino)-6-chloro-s-triazine (4)
2-4-Difluoroaniline (0.01 mol, 1.29g in 10mL acetone) was added slowly to compound (3) (0.01 mol, 2.77g in 35mL acetone) with constant stirring for 6 hours at room temperature. Periodically, sodium carbonate solution (0.005 mol, 0.53g in 10mL water) was added drop wise to neutralized HCl evolved during the reaction. The progress of the reaction was monitored on TLC plate. Finally, the content was poured into crushed ice. The solid separated out was filtered, washed with water, dried and recrystallized from alcohol to give (4).
Preparation of 2,4-bis-(2',4'-difluorophenylamino)-6-(4'-acetylphenylamino)-s-triazine (5)
4-Aminoacetophenone (0.01 mol) and compound (4) (0.01 mol) were dissolved in acetone (40mL). The reaction mixture was refluxed for 8 hours. Periodically, sodium carbonate solution (0.005 mol, 0.53g in 10mL water) was added to neutralized HCl evolved during the reaction. The progress of the reaction was monitored on TLC plate. After completion the reaction the content was poured into crushed ice. The solid separated out was filtered, washed with water, dried and recrystallised from alcohol to give (5).
Preparation of 2,4-bis-(
Compound (5) (0.01 mol) was dissolved in DMF (30mL) and 3-methoxybenzaldehyde (0.01 mol) was added to it. Then solution of KOH (5mL of 40%) was added to the reaction mixture with constant stirring at room temperature. The progress of the reaction was monitored on TLC plate. After completion the reaction mixture was poured into crushed ice and neutralised with HCl. The product separated out was filtered, washed with water, dried and recrystallised from alcohol. Similarly the remaining compounds (6b-f) were prepared by this method. 
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Preparation of 2,4-bis-(2',4'-difluorophenylamino)-6-[4′-{2″-amino-6″-(3″′-methoxyphenyl)-pyrimidin -4″-yl}phenylamino]-s-triazine (7a)
Compound 6a (0.01 mol) was dissolved in ethyl alcohol (25mL) and guanidine hydrochloride (0.01 mol) was added to it. Then solution of KOH (5mL of 40%) was added to the reaction mixture and refluxed for 8 hours. The progress of the reaction was monitored on TLC plate. After completion the reaction mixture was cooled and poured into crushed ice and neutralised with dilute HCl. The product separated out was filtered, washed with water, dried and recrystallised from alcohol to give 7a. Similarly the remaining compounds (7b-f) were prepared by this method. 
Compound (7a)
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Preparation of 2,4-bis-(2',4'-difluorophenylamino)-6--[4'-{1''-phenyl-5''-(3'''-methoxyphenyl)-2''-pyrazolin-3''-yl} phenylamino]-s-triazine (8a)
Compound 6a (0.01 mol) was dissolved in alcohol (25mL) and phenyl hydrazine hydrochloride (0.01 mol, 1.44 g) in 40 mL alcohol was refluxed for 10 hours in the presence of 40 % KOH (3mL). The progress of the reaction was monitored on TLC plate. After completion the reaction mixture was cooled and poured into crushed ice and neutralized with dilute HCl. The product separated out was filtered, washed with water, dried and recrystallised from alcohol to give 8a. Similarly the remaining compounds (8b-f) were prepared by this method. 
Compound (8a)
Results and Discussion
The in vitro antibacterial and antifungal activities of the compounds are shown in (Table 2) . The MICs (μg/mL) were carried out by broth microdilution method as described by Rattan 18 . The newly synthesised compounds (6a-f), (7a-f) and (8a-f) were screened for their antibacterial activity against two Gram positive bacteria srains: S. aureus MTCC96 and S. pyogenes MTCC442 and two Gram negative bacteria E.coli MTCC443 and P. aeruginosa MTCC1688 and compared with standard drug: Ampicillin and Antifungal activity against C. albicans MTCC227, A. niger MTCC282 and A. clavatus MTCC1323 organisms was determined by same method and compared with standard drug: Griseofulvin. Antibacterial Activity From the screening results (Table - 2), The result shows that compounds 6c , 6d , 6e , 7c , 8a , 8c and 8f exhibited good activity (25 -125 µg/mL) against E. coli ; compound 8e exhibited good activity (50 -100 µg/mL) against P. aeruginosa . In Gram positive bacterial strains compounds 6b , 6f , 7a , 8b , 8c and 8d showed good to very good activity (25 -150 µg/mL) against S. aureus ; whereas compound 7a showed good activity (62.5 -100 µg/mL) against S. pyogenes compared with Ampicillin. All others compounds show moderately active or less active against all bacterial strains.
Antifungal Activity
From the screening results (Table -2) , Compounds 6a , 6b , 7b , 7c , 7e , 8a and 8b showed good activity against C. albicans compared with Griseofulvin, while compounds 6f and 8c showed very good activity against C. albicans.
Conclusion
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